Scientists hope that a new approach to vaccine development, combined with improved surveillance of potential future threats of outbreak, could help to massively reduce the impact of deadly diseases such as Ebola, Marburg and Lassa fever.
Researchers have developed a genome-editing tool for the potential treatment of mitochondrial diseases: serious and often fatal conditions which affect 1 in 5,000 people.
Researchers have developed a new way to target the toxic particles that destroy healthy brain cells in Alzheimer’s disease.
The Chemistry of Health building, a new facility dedicated to the use of chemical techniques to combat disease, in particular neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases, was officially opened today in Cambridge.
A new Rising Path, designed to offer a fresh perspective on Cambridge University Botanic Garden’s historic Systematic Beds, will open to the public on Saturday (September 22, 2018).
Three Cambridge researchers are among the new Fellows announced today by the Royal Academy of Engineering, in recognition of their outstanding contributions.
Researchers at the University of Cambridge and the University of Oxford have discovered a new molecule that plays a key role in the immune response that is triggered by influenza infections. The molecule, a so-called mini viral RNA, is capable of inducing inflammation and cell death, and was produced at high levels by the 1918 pandemic influenza virus. The findings appeared in Nature Microbiology yesterday (September 17).
Vice-Chancellor's statement following the publication of the Migration Advisory Committee report.